Clinical Trial Update: Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery [Phase 3]

View source ↗

Summary

Phase 3 trial updates evaluate gemcitabine with or without erlotinib followed by the same regimen with or without radiation therapy and capecitabine or fluorour…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma
• Pancreatic Cancer
• Pancreatic Ductal Adenocarcinoma
• Pancreatic Intraductal Papillary Mucinous Neoplasm

Drugs mentioned

• Adrucil (5-fluorouracil)
• Gemzar (gemcitabine)
• Tarceva (erlotinib)
• Xeloda (capecitabine)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Pancreatic Adenocarcinoma, Pancreatic Ductal Adenocarcinoma | Phase 3 | Status: COMPLETED | Results posted: 2024-10-24